» Articles » PMID: 15165921

Effect of Pravastatin on Myocardial Perfusion After Percutaneous Transluminal Coronary Angioplasty

Overview
Journal Am J Cardiol
Date 2004 May 29
PMID 15165921
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the effect of pravastatin on coronary perfusion after percutaneous transluminal coronary angioplasty. An exercise test performed within 2 weeks after percutaneous transluminal coronary angioplasty induced reversible perfusion defects in 66% of patients taking pravastatin and 64% of those taking placebo. At follow-up, the exercise test still induced reversible perfusion defects in 3% of patients taking pravastatin and 29% of those taking placebo.

Citing Articles

Incidence, Predictors, and Prognosis of Coronary Slow-Flow and No-Reflow Phenomenon in Patients with Chronic Total Occlusion Who Underwent Percutaneous Coronary Intervention.

Wang Y, Zhao H, Wang C, Zhang X, Tao J, Cui C Ther Clin Risk Manag. 2020; 16:95-101.

PMID: 32110027 PMC: 7038390. DOI: 10.2147/TCRM.S233512.


ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.

Padro T, Manfrini O, Bugiardini R, Canty J, Cenko E, De Luca G Cardiovasc Res. 2020; 116(4):741-755.

PMID: 32034397 PMC: 7825482. DOI: 10.1093/cvr/cvaa003.


Effect of statins on coronary blood flow after percutaneous coronary intervention in patients with stable coronary artery disease.

Cerit L, Duygu H, Gulsen K, Gunsel A Neth Heart J. 2016; 25(4):258-263.

PMID: 27561280 PMC: 5355380. DOI: 10.1007/s12471-016-0883-x.


Women and Ischemic Heart Disease: Recognition, Diagnosis and Management.

Park S, Merz C Korean Circ J. 2016; 46(4):433-42.

PMID: 27482251 PMC: 4965421. DOI: 10.4070/kcj.2016.46.4.433.


Sex-Specific Disparities in Risk Factors for Coronary Heart Disease.

Rosen S, Henry S, Bond R, Pearte C, Mieres J Curr Atheroscler Rep. 2015; 17(8):49.

PMID: 26108894 DOI: 10.1007/s11883-015-0523-8.